drugset / Trial / NCT00496847
Efficacy and Safety of PERIOGEN in the Treatment of Periodontal Bone Defect
RandomizedParallel-groupDouble-blindTreatment
Summary
PERIOGEN, containing rhPDGF and -beta-TCP, promotes gingival healing and corrects periodontal defects. This study will test the safety and efficacy of PERIOGEN in the treatment of periodontal disease
Timeline
- Start
- 2007-08
- Primary completion
- 2008-08
- Completion
- 2009-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Beta TCP | Other / unclassified | 0.5 g | Other |
| Comparator | Beta TCP | Other / unclassified | 0.5 g | Other |
| Subject | rhPDGF-BB | Protein / enzyme biologic | 0.3 mg/ml | Other |